<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03609411</url>
  </required_header>
  <id_info>
    <org_study_id>CRC_GHN_2018_002</org_study_id>
    <nct_id>NCT03609411</nct_id>
  </id_info>
  <brief_title>Splenectomy During Whole Liver Transplantation</brief_title>
  <official_title>Splenectomy During Whole Liver Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Indications for splenectomy during whole liver transplantation remain controversial and
      splenectomy is often avoided because of common complications. The objective is to evaluate
      specific complications of these combined procedures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data on patients who underwent splenectomy during liver transplantation were retrospectively
      analyzed . Participants underwent splenectomy as part of routine medical care. Patients
      undergoing simultaneous liver transplantation and splenectomy were matched to a
      non-splenectomy group.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Actual">January 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>3-month post-operative mortality</measure>
    <time_frame>At 3 months post surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative morbidity</measure>
    <time_frame>3 months post surgery</time_frame>
    <description>Incidence of portal-vein thrombosis within 3 months post liver transplantation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>One-year mortality</measure>
    <time_frame>One year after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality at 5 years</measure>
    <time_frame>Five years after surgery</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">141</enrollment>
  <condition>End Stage Liver Disease</condition>
  <arm_group>
    <arm_group_label>Splenectomy</arm_group_label>
    <description>Patients undergoing liver transplantation with simultaneous splenectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Liver transplantation</arm_group_label>
    <description>Patients undergoing liver transplantation only</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Splenectomy</intervention_name>
    <description>Splenectomy was performed after hepatectomy, in an extra-hilar manner with manual ligation of splenic vessels.</description>
    <arm_group_label>Splenectomy</arm_group_label>
    <other_name>Liver transplantation</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Among the 906 liver transplantations performed between 1994 and 2013 at the Liver
        Transplant Department of the Croix-Rousse University Hospital, Lyon-France, all 47 liver
        transplantations with simultaneous splenectomy were included and compared to 94 transplant
        recipients without splenectomy after a 1:2 matching for gender, age at transplantation,
        year of liver transplantation, MELD score, platelet level and presence of hepatocellular
        carcinoma.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing liver transplantation between 1994 and 2013

        Exclusion Criteria:

          -  Data from living donor patients, split liver transplantation, patients with pre- or
             post-operative splenectomy in medical history, and patients under 16 years were
             excluded from analysis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Hopital de la Croix-Rousse</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 17, 2018</study_first_submitted>
  <study_first_submitted_qc>July 31, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 1, 2018</study_first_posted>
  <last_update_submitted>July 31, 2018</last_update_submitted>
  <last_update_submitted_qc>July 31, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>End Stage Liver Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

